Preprint / Version 1

Epigenetics and Neurological Disorders

##article.authors##

  • Anika Chakrabarti Lexington High School

DOI:

https://doi.org/10.58445/rars.1655

Keywords:

Epigenetics, Neuroscience, Genes, Gene Expression, Therapeutics, Huntington's Disease, Alzheimer's Disease

Abstract

Epigenetics, with its diverse mechanisms such as DNA methylation, histone acetylation, and ncRNAs, holds significant therapeutic potential for a wide range of disorders and diseases. Its intrinsic adaptability prevents DNA from enduring permanent damage while at the same time, regulating gene expression in reversible and plastic ways. It is a natural and dynamic process that needs continuous regulation for our bodies to function properly. However, this essential machinery can be disrupted by various factors. This paper will explore the molecular and cellular changes that occur in the brain due to epigenetic dysregulation, and how these changes are correlated to neurodegenerative diseases such as Alzheimer's and Huntington’s disease.

References

Mehler, M. F. (2008). Epigenetics and the nervous system. Annals of Neurology, 64(6),

–617. https://doi.org/10.1002/ana.21595

Kubota, T., Hirasawa Takae, & Miyake, K. (2012). Epigenetic Mechanisms and

Therapeutic Perspectives for Neurodevelopmental Disorders. Pharmaceuticals, 5(4),

–383. https://doi.org/10.3390/ph5040369

MacDonald, W. A. (2012). Epigenetic Mechanisms of Genomic Imprinting: Common

Themes in the Regulation of Imprinted Regions in Mammals, Plants, and Insects.

Genetics Research International, 2012, 1–17. https://doi.org/10.1155/2012/585024

Jakovcevski, M., & Schahram Akbarian. (2012). Epigenetic mechanisms in neurological

disease. Nature Medicine, 18(8), 1194–1204. https://doi.org/10.1038/nm.2828

Jorge Alejandro Alegría-Torres, Baccarelli, A., & Bollati, V. (2011). Epigenetics and

lifestyle. Epigenomics, 3(3), 267–277. https://doi.org/10.2217/epi.11.22

Vivek Kumar Sharma, Mehta, V., & Thakur Gurjeet Singh. (2020). Alzheimer's Disorder:

Epigenetic Connection and Associated Risk Factors. Current Neuropharmacology, 18(8),

–753. https://doi.org/10.2174/1570159x18666200128125641

Clinic, C. (2023). Huntington's Disease: What It Is, Symptoms & Treatment. Cleveland

Clinic. https://my.clevelandclinic.org/health/diseases/14369-huntingtons-disease

Hodges, A., Strand, A. D., Aragaki, A. K., Kuhn, A., Thierry Sengstag, Hughes, G.,

Elliston, L. A., Hartog, C., Goldstein, D. R., Thu, D., Hollingsworth, Z. R., Collin, F.,

Synek, B., Holmans, P. A., Young, A. B., Wexler, N. S., Delorenzi, M., Kooperberg, C.,

Augood, S. J., & Richard L.M. Faull. (2006). Regional and cellular gene expression

changes in human Huntington’s disease brain. Human Molecular Genetics, 15(6),

–977. https://doi.org/10.1093/hmg/ddl013

Ross, C. A., & Poirier, M. A. (2004). Protein aggregation and neurodegenerative disease.

Nature Medicine, 10(S7), S10–S17. https://doi.org/10.1038/nm1066

Laetitia Francelle, Lotz, C., Tiago Outeiro, Brouillet, E., & Merienne, K. (2017).

Contribution of Neuroepigenetics to Huntington's Disease. Frontiers in Human

Neuroscience, 11. https://doi.org/10.3389/fnhum.2017.00017

Downloads

Posted

2024-09-21